Evidence map›Paper›PMID 23028440›Full record

ArticlePloS one2012

Mutation in Phex gene predisposes BALB/c-Phex(Hyp-Duk)/Y mice to otitis media.

Fengchan Han, Heping Yu, Ping Li, Jiangping Zhang, Cong Tian, Hongbo Li, Qing Yin Zheng

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Role of a novel mouse mutant of theFrontiers in neurology · 2022
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Panel 3: Genetics and Precision Medicine of Otitis Media.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2017
    Review
  9. Article
  10. What have we learned from murine models of otitis media?Current allergy and asthma reports · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Fengchan HanThe Transformative Otology and Neuroscience Center, Binzhou Medical University, Yantai, Shandong, People's Republic of China.
Heping Yu
Ping Li
Jiangping Zhang
Cong Tian
Hongbo Li
Qing Yin Zheng
Case Western Reserve University · USBinzhou Medical University · CNBinzhou University · CNJackson Laboratory · US

Funding

Deciphering the Usher I protein interactome using a genetic approachR01DC009246 · NIDCD · CASE WESTERN RESERVE UNIVERSITY · PI ZHENG, QING Y · 2009 to 2013
$1.6M
Transcriptome and Proteome Analysis of Mouse Inner EarsR01DC007392 · NIDCD · JACKSON LABORATORY · PI ZHENG, QING Y · 2005 to 2007
$1.0M
Identify and Develop Mouse Models for Otitis MediaR21DC005846 · NIDCD · JACKSON LABORATORY · PI ZHENG, QING Y · 2003 to 2005
$562k
NIDCD NIH HHS R01 DC007392NIDCD NIH HHS R01DC007392NIDCD NIH HHS R01 DC009246NIDCD NIH HHS R21 DC005846NIDCD NIH HHS R21DC005846
6 · The paper itself

Abstract

Genetic susceptibility underlying otitis media (OM) remains to be understood. We show in this study that mutation in Phex gene predisposes the BALB/c-Phex(Hyp-Duk)/Y (abbreviated Hyp-Duk/Y) mice to OM, which occurs at post-natal day 21 (P21) with an average penetrance of 73%. The OM was identified by effusion in the middle ear cavity and/or thickening of middle ear mucosae, and was characterised by increase in goblet cells, deformity of epithelial cilia and higher expression of proliferating cell nuclear antigen (PCNA) in cells of the middle ear mucosae. Moreover, the transcription levels of Tlr2, Tlr4, Nfkb1, Ccl4, Il1b and Tnfα in the ears of the Hyp-Duk/Y mice at P35 were significantly upregulated, compared to those of the controls. Higher expression levels of TLR2, TLR4, NF-κB and TNF-α in the middle ears were demonstrated by immunohistochemistry (IHC). However, the OM in the mice was not prevented by azithromycin administration from gestational day 18 to P35. Further study showed that, in contrast to the low mRNA levels of Phex gene in the ears of the Hyp-Duk/Y mice, the mRNA level of Fgf23 was significantly elevated at P9, P14, P21 and P35. Meanwhile, mRNA levels of EP2 (PGE2 receptor), which expressed in the middle ear epithelia as demonstrated by IHC, were already increased at P14 even before the occurrence of OM, indicating that PGE2, an inflammatory mediator, is involved in the OM development in the mutants. Taking together, Phex mutation primarily up-regulates gene expression levels in FGF23 mediated pathways in the middle ears, resulting in cell proliferation and defence impairment at the mucosae and subsequently bacterial infection. The Hyp-Duk/Y mouse is a new genetic mouse model of OM.

Indexed as

Genetic Predisposition to DiseaseMutationAnimalsCell ProliferationCiliaCytokinesDisease Models, AnimalExonsFibroblast Growth Factor-23Gene Expression RegulationGene OrderGoblet CellsInflammationInflammation MediatorsMiceMice, Inbred BALB CCytokinesFgf23 protein, mouseFibroblast Growth Factor-23Inflammation MediatorsPHEX Phosphate Regulating Neutral Endopeptidase

Identifiers

PMID23028440
PMCPMC3461009
OpenAlexW2102678152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.